Once-daily atenolol in hypertensive Zimbabwean blacks. A double-blind trial using two different doses

S Afr Med J. 1981 Jul 11;60(2):47-8.

Abstract

A double-blind within-patient study was carried out on Zimbabwean Blacks to investigate the effect of once-daily atenolol on hypertension in doses of 100 and 200 mg/d. Atenolol 200 mg produced significant changes in diastolic pressure readings taken in the supine and standing positions and after exercise; with atenolol 100 mg modest but non-significant changes occurred. These findings are less impressive than those previously reported in White subjects. We conclude that beta-adrenoceptor blocking agents should not be used as drugs of first choice for hypertension in our Black population.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Atenolol / administration & dosage*
  • Black People
  • Black or African American*
  • Blood Pressure / drug effects
  • Clinical Trials as Topic
  • Dose-Response Relationship, Drug
  • Double-Blind Method
  • Female
  • Humans
  • Hypertension / drug therapy*
  • Male
  • Middle Aged
  • Propanolamines / administration & dosage*
  • Pulse / drug effects
  • Zimbabwe

Substances

  • Propanolamines
  • Atenolol